Peggy Sotiropoulou

Peggy Sotiropoulou

Company: Celyad Oncology

Job title: Head of Research & Development


Panel Discussion: Best Practices to Prevent Rejection and Achieve Long Lasting Responses 1:00 pm

• Review methods to prevent rejection and improve long term durability of allogeneic cells • Compare the different safety profiles of alternative cell types and the qualities that prevent rejection • Understand the best in class approaches for achieving increased depth of response and efficacyRead more

day: Track A - Day 2 - 3PM

Differentiated Non-Gene Edited Technologies to Generate Off-The-Shelf CAR-T Cells for the Treatment of Hematopoietic and Solid Malignancies 11:35 am

• Leveraging non-gene edited technologies to disrupt TCR signaling to generate allogeneic CAR T cells • Exploiting natural receptor/ligand interactions for CAR T cell therapy of metastatic colorectal cancer • Discussing the first-in-class shRNA-based BCMA-targeting allogeneic CAR T candidate for the treatment of multiple myelomaRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.